Catheter interventions in Congenital, structural and valvular heart disease, atrial fibrillation, stroke prevention and heart failure
CSI will again join forces with the University of California, San Francisco to provide a meeting that will give attendees a comprehensive overview of major topics in catheter and device therapy for structural and valvular heart disease, in addition to novel therapies for atrial fibrillation and heart failure. There will also be sessions on catheter therapy for congenital heart disease in adults and innovation. The program will include lectures from leading experts in the field, case presentations with panel discussions and recorded cases, a review of ongoing and future studies and training sessions.
The congress is designed for interventional cardiologists, cardiothoracic surgeons, anesthesiologists, EP specialists, imaging specialists, nurses, technicians and any other medical specialty involved in these procedures. With a focus on innovation we will also welcome device companies, engineers, start-ups and venture capitalists.
Why should you attend? CSI San Francisco will give you the opportunity to rub shoulders with key opinion leaders, such as Martin Leon, John Carroll, Adam Greenbaum and many more. Our goal is to maximize interaction and debate between all our participants within a friendly and personal atmosphere. Participants are actively encouraged to submit cases for presentation, ask questions share their ideas and experiences. CSI San Francisco will be an opportunity for you to learn the latest techniques, see the newest devices and meet the most experienced interventionists in the field.
CSI San Francisco congress attendees will be accredited CME points. Please join us in San Francisco for what we are confident will be an enjoyable and interactive educational meeting.
Randy J. Lee, Vaikom S. Mahadevan, Horst Sievert, Gareth Morgan
On behalf of the CSI San Francisco Board of Directors